Jenburkt Pharmaceuticals Limited reported earnings results for the fourth quarter ended March 31, 2022. For the fourth quarter, the company reported sales was INR 282.9 million compared to INR 295.6 million a year ago. Revenue was INR 295.68 million compared to INR 308.19 million a year ago. Net income was INR 34.49 million compared to INR 38.77 million a year ago. Basic earnings per share from continuing operations was INR 7.51 compared to INR 8.45 a year ago.